Women's Health MRI

>

Latest News

Key MRI Findings Predictive of Treatment Response for Unresectable Hepatocellular Carcinoma
Key MRI Findings Predictive of Treatment Response for Unresectable Hepatocellular Carcinoma

July 14th 2025

For patients with unresectable hepatocellular carcinoma, a pre-treatment MRI finding of LI-RADS tumor in vein was associated with over an 86 percent lower likelihood of responding to transcatheter arterial chemoembolization (TACE) and targeted immunotherapy.

FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease

July 9th 2025

New FDA-Approved Dosing Schedule for Donanemab May Reduce ARIA-E Rates
New FDA-Approved Dosing Schedule for Donanemab May Reduce ARIA-E Rates

July 9th 2025

Assessing Post-Treatment MRI for Predicting Neoadjuvant Chemoimmunotherapy Response for Triple-Negative Breast Cancer
Assessing Post-Treatment MRI for Predicting Neoadjuvant Chemoimmunotherapy Response for Triple-Negative Breast Cancer

July 3rd 2025

FDA Clears SmartSpeed Precise MRI Software from Philips
FDA Clears SmartSpeed Precise MRI Software from Philips

July 2nd 2025

Video Interviews

More News

© 2025 MJH Life Sciences

All rights reserved.